Neonatal hyperbilirubinemia
Conditions
Interventions
Control group:Routine care combined with blue light therapy
Intervention group:Routine care combined with blue light therapy and Traditional Chinese Medicine (TCM) fumigation and washing
Sponsors
Zhongda Hospital Affiliated to Southeast University
Eligibility
Sex/Gender
All
Age
1 Years to 30 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of Neonatal Hyperbilirubinemia (2025 Edition): serum bilirubin = 257 µmol/L; rapid increase in bilirubin levels, with transcutaneous bilirubin (TcB) rising > 0.3 mg/dl per hour. 2.Gestational age = 34 weeks, appropriate for gestational age (AGA), and a 1-minute Apgar score = 8. 3.Informed consent signed by the patient's legal guardian
Exclusion criteria
Exclusion criteria: 1.Severe Infections: Such as septicemia or purulent meningitis presenting with severe clinical symptoms. 2.Gastrointestinal Diseases: Patients with anal disorders, gastrointestinal perforation or hemorrhage, severe diarrhea, or neonatal necrotizing enterocolitis (NEC). 3.Skin Infections: Pediatric patients with skin defects, omphalitis, varicella (chickenpox), or bullous epidermal symptoms. 4.Congenital and Genetic Abnormalities: Patients with biliary atresia, severe malformations, or chromosomal and genetic abnormalities. 5.Prior Treatment History: Patients who have received treatment at other institutions or those with secondary admissions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum total bilirubin level; | — |
Secondary
| Measure | Time frame |
|---|---|
| daily decrease in transcutaneous bilirubin;total phototherapy time; time for meconium to turn yellow; | — |
Countries
CHINA
Contacts
Public ContactLu Xiaosu
Zhongda Hospital Affiliated to Southeast University
Outcome results
None listed